Merck Serono

Royalty Monetization$55 Million

Nov 2008

MarketerMerck Serono

Cetrotide® is a fertility drug commonly used in in-vitro fertilization procedures. The gonadotropin releasing hormone (GnRH) antagonist is used to prevent premature ovulation in controlled ovarian stimulation prior to assisted reproductive technologies (ART).

News